A novel in vivo model for breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch (2013)
- Authors:
- USP affiliated authors: TIÉZZI, DANIEL GUIMARÃES - FMRP ; SICCHIERI, RENATA DANIELLE - FMRP ; MILANEZI, CRISTIANE MARIA - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS MAMÁRIAS (EXPERIMENTAÇÃO); MODELOS ANIMAIS DE DOENÇAS
- Language: Inglês
- Imprenta:
- Publisher: AACR
- Publisher place: Washington
- Date published: 2013
- Source:
- Título do periódico: Abstracts
- Conference titles: Annual Meeting of the American Association for Cancer Research
-
ABNT
TIEZZI, Daniel Guimarães et al. A novel in vivo model for breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch. 2013, Anais.. Washington: AACR, 2013. . Acesso em: 29 maio 2024. -
APA
Tiezzi, D. G., Antonio, H. M. R., Sicchieri, R. D., Milanezi, C. M., Mandarano, L. R. M., Coelho, A. A., & Andrade, J. M. de. (2013). A novel in vivo model for breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch. In Abstracts. Washington: AACR. -
NLM
Tiezzi DG, Antonio HMR, Sicchieri RD, Milanezi CM, Mandarano LRM, Coelho AA, Andrade JM de. A novel in vivo model for breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch. Abstracts. 2013 ;[citado 2024 maio 29 ] -
Vancouver
Tiezzi DG, Antonio HMR, Sicchieri RD, Milanezi CM, Mandarano LRM, Coelho AA, Andrade JM de. A novel in vivo model for breast cancer hypoxia reveals an epithelial-to-mesenchymal transition switch. Abstracts. 2013 ;[citado 2024 maio 29 ] - Genetic profile analysis of tumor stem cells in locally advanced breast cancer
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- ABCG2 is a potential marker of tumor-initiating cells in breast cancer
- CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
